Kosaraju Sridhar 的 Form 4 申報
10x Genomics, Inc.（TXG），2021/10/27 申報
- 申報編號
- 0001567619-21-018801
- 申報時間
- 2021/10/27
- 交易日
- 2021/10/25
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 5 筆非衍生性交易。公開市場賣出合計 $24.9 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Kosaraju SridharCIK 0001651325 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/10/25 | Class A Common Stock | S賣出處分 | −100 | $163.85 | −$16,385 | 7,400 | 間接 | |
| 2021/10/25 | Class A Common Stock | S賣出處分 | −600 | $165.14F3 | −$99,084 | 6,800 | 間接 | |
| 2021/10/25 | Class A Common Stock | S賣出處分 | −400 | $166.60F4 | −$66,640 | 6,400 | 間接 | |
| 2021/10/25 | Class A Common Stock | S賣出處分 | −100 | $167.63 | −$16,763 | 6,300 | 間接 | |
| 2021/10/25 | Class A Common Stock | S賣出處分 | −300 | $168.68F5 | −$50,604 | 6,000 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F3
This transaction was executed in multiple trades at prices ranging from $164.57 to $165.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $166.23 to $167.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $168.49 to $168.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。